chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a RN concerning her 6 yr old white grandson with no allergies or medical conditions who, at one year of age, was vaccinated with a dose of varicella virus vaccine. There was no illness at the time of vaccination. Recently the pt had a case a break through chickenpox. He had more than 50 lesions all over his body and a fever of 102. He was sick for seven days and was given a medication by his doctor but the name of the medication was not known. The nurse reported that there was a mild outbreak in the pt's school. Subsequently, the pt recovered from breakthrough chickenpox.  A product quality complaint was not involved. Follow up information was received from a consumer who  reported that on 18Feb05 at 17:00 the pt had a full chickenpox outbreak with more than 50 pox and a high fever of 103 degrees along with vomiting and bodyaches. Clinical observation by the pt's primary care physician was required. The pt recovered on 25Feb05. No further information is expected.
Had chest pains that felt tight, especially in the morning. Was instructed to go to ER by local doctor. I was diagnosed with having costochondritis. I was prescribed naproxen which I was told is basically Motrin. After prescription ran out I continued taking Motrin when I felt pain. It is still present but it is much more mild and I experience pain much less frequently now. Planning on incorporating stretching/Motrin until it subsides, or if it gets worse, following up with a dr.
My symptoms were pretty mild. I had a low-grade fever, some minor body aches, runny nose. I was still able to smell and taste. It was just similar to flu-like symptoms, but I knew I had COVID-19 because my partner had just tested positive two days before I started having symptoms. I took an at-home test which came back positive. So I had to delay my returning flight until my symptoms cleared out. I called my doctor who prescribed me Paxlovid to help rid my symptoms sooner. Now, I just have a common cold that was given to me.
Home duonebs, budesonide and BiPAP  Intubated on 12/30 at outside hospital.  Ventilator settings: CMV - CXR at OSH showed increasing bilateral mixed interstitial alveolar opacities with small bilateral pleural effusions - Ventilator bundle ordered - COVID+ on 12/28/21, previous infection
After the vaccination, there was no chair in pharmacy so that he could sit and wait the 15 minutes inside the place, so we had to go to the car to wait the 15 minutes, that was when the person began to feel very cold and lost consciousness for about 2 minutes. His head fell and also his upper limbs stiffened with twisted hands as if it were a convulsion, as if it were a tonic phase. His skin turned white and he didn't react. I put alcohol gel all over his face and body, then he began to react, little by little his body color returned but he does not remember anything that happened in those minutes.
She was immediately sick.  Very sick for 4 more days.  Kept getting worse.  Dec 20 put in hospital.  Dec 25 to ICU.  Dec 27 respirator.  Died 1/17/08.  2/21/08 Reviewed hospital medical records which included clinic visit & vax record of 11/28/07.  Database updated.  Patient w/palpitations intermittently when anxious or blood sugar low, 10# wt loss over past several months since the death of parent. H&P indicates patient experienced sinusitis, fever, chills, sore throat, nasal congestion, postnasal drip, swollen cervical lymph nodes & productive cough x 3 wks.  Dx w/bronchitis & pneumonia & tx w/oral antibiotics as outpatient w/o increasing fever, SOB & weakness.  Admitted 12/20/07-01/17/2008 w/community acquired pneumonia & dehydration.  Consults by pulmonogy, surgery & ID.  Conditioned worsened & was intubated & transferred to ICU.  Developed pneumothorax s/p transbronchial biopsy & had chest tube placed.  Developed acute ARDS & was trached 1/8/08. Continued to deteriorate & expired 1/17/2008. FINAL DX: none provided on D/C summary.  No autopsy done per med records.  Death certificate requested from funeral home. 2/21/08 Reviewed death certificate which states COD as respiratory failure with pneumonia as underlying cause.
I experienced a rash of red stripes that appear throughout the day on different parts of my body and it is very itchy. My hands and feet turn red as well.
Pt. developed a fever and rash on 6-29-15. Pt. seen in E.R 6-29-15 for fever, rash and tender abdomen. Pt. discharged to home in improved condition. Told to admin frequent, small amounts of fluids. Return to ED if worsening abdom pain, persistent vomiting, inability to tolerate fluids.
This 38 year old AA male has NO eczema or any skin condition other than a personnel and strong family history of dry skin. He received his primary SMPX/AVA vaccine 2 says ago and Hep A/B and typhoid on 8/15/08. Today 8/22/08 found multiple "black lesions" over torso and extremities, nonpruritic, nonpustule. Has a few bumps to right lower leg. Symptoms: Rash, diffuse.
She started to have a fever of 100.4 about 3:00 PM on 09/16/2013.  I gave her Tylenol to lower the temperature.  She continued to have a fever off and on for the night and following day.  About 6:30 AM on 09/17/2013, she had diarrhea that leaked out of her diaper down her left leg onto her foot.  On the morning of 09/18/2013, she was cranky and fussy.  I was unable to calm her.  She even refused her pacifier that she loved.  About 11:00 AM, she was found on her back without a pulse and not breathing.  She was pronounced dead at the hospital later that day.
EXTREME vertigo upon waking up in the morning, so bad I couldn't move or eat, vomiting when I tried to get up to the bathroom, no fever or other symptoms. Could not go about my daily activities (eg relative had to drive the car for me to return home). With meclizine I was able to manage someone driving me in the car and airplane ride home. No vision change, hearing loss or numbness or weakness.  Lasted 3 days, though progressively better each day and periodically for months after when going from sitting to lying down.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Pertinent medical history, concurrent conditions and concomitant medications were not reported. On 22-MAR-2016 the patient was vaccinated with a dose of PROQUAD (Merck) lot # L044055 expiry date: 02-MAY-2017 in the right thigh. On 23-MAR-2016, the patient sought medical attention by calling the facility and stated that the patient had developed that morning (23-MAR-2016) a raised red bump at the injection site that was tender and warm to touch. There was no product quality complaint. The outcome of events was unknown. Causality assessment was not reported. Additional information has been requested.
Pt  reported nausea and felt like fainting 23 mins after vaccination.  Pt stable and released from vaccination site.
Throat fullness/tightness, heart racing, hot feeling, chest tightness and wheezing approximately 26 to 27 minutes or so after the vaccine
Patient came into the pharmacy today to discuss potential allergic reaction to SHINGRIX. According to patient, she noticed immediate pain in her arm after recieving vaccine. By bedtime, she had "pain all over." She took MOTRIN to relieve the pain for this. Then she noticed that she developed a rash on both thighs, both arms, and across her chest. She took BENADRYL at bedtime that night and by the following morning, pain and rash were gone.
Patient received 0.5 ml vs 0.25 ml dose for their first booster
Atopic eczematous dermatitis.  Note: the phone number provided is DSN.
Initial misuse report received from a pharmacist on 02-Oct-2013. The 03-months-old patient had received FLUZONE (dose unknown). No adverse event was reported. List of documents held by sender: none.
urinary tract infection (UTI); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URINARY TRACT INFECTION (urinary tract infection (UTI)) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006821A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced URINARY TRACT INFECTION (urinary tract infection (UTI)). The patient was treated with NITROFURANTOIN at a dose of 100mg for 7 days. At the time of the report, URINARY TRACT INFECTION (urinary tract infection (UTI)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported
9 mo old for well child visit. Because there was a combo vaccine available the clinician gave a KINRIX instead of individual vaccines. Clinical states that she was unaware of the age requirements since we do not carry this vaccine in our private stock and it is not used often. Of note, nowhere on the vaccine box does it state age requirements.
Patient was administered Moderna Spikevax 12+ at a Pharmacy and experienced severe psoriasis flare-up leading to pustular psoriasis.  Pus secretions were severe and lead to clumping in the hair. The patient experienced severe scalp and head pain for four days and self-administered ibuprofen before being seen by a dermatologist on six days later.
This spontaneous report as received from a treating pharmacist vial a field employee refers to a male patient of unknown age. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX for prevention of shingles (dose, frequency, lot#, expiration date unknown, injections as reported route). On an unknown date, the following day of receiving ZOSTAVAX, the patient called to report a rash had developed on his leg. Action taken with therapy and outcome of the event were unknown. Additional information has been requested.
Fever of 100-101 deg. F two days after MMR, DTaP, Hib and also cranky, clingy, faint rash.
This initial non-serious spontaneous case, was received on 01-Nov-2017, from a physician, concerning an adult male patient of unspecified age. This refers 39 of 84 patients. On an unspecified date in Oct-2017 (between 25-Oct-17 to 27-Oct-17), the patient was administered with AFLURIA (batch number: 14649211A, dose, route of administration, anatomical location and expiry date: not reported). It was reported that, the vaccine was stored in cooler with ice packs for 6 days and had reached unknown temperature during transport (explicitly considered as incorrect product storage) instead of storing at 36-degree F and 46-degree F (2-degree C and 8-degree C). And the same was administered to the patient (explicitly considered as drug administration error). The reporter stated that the temperature was not monitored on 24-Oct-2017 (could have been between 2-8C, but not certain) and there were no reports of adverse effect after vaccination (no adverse effect). The vaccine had been discarded. Follow up received on 09-Nov-2017 from a physician: Added event (no adverse effect) and reporter's comment. Amended narrative accordingly.
Swelling, erythema, and warmth of forearm; same arm as where vaccine was placed the day before.
Fever; Nausea; This is a spontaneous report received from a non-contactable reporter(s) (Pharmacist).  A 54 year-old female patient (unknown if pregnant) received bnt162b2 (BNT162B2), administration date 12Jan2022 (Lot number: FD7218) at the age of 54 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (dose number=2, Prev dose product=COVID 19, Prev dose brand unknown= true, Prev dose brand name unknown = Covid 19 vaccine, Prev dose lot unknown= true, Prev dose lot unknown reason = not available/provided to reporter at the time of report completion.), for COVID-19 immunization; Covid-19 vaccine (dose number= 1, Prev dose product=COVID 19, Prev dose brand unknown= True, Prev dose lot number unknown, prev dose brand name unknown= Covid 19 vaccine, Prev dose lot unknown= true, Prev dose lot unknown reason = not available/provided to reporter at the time of report completion), for COVID-19 immunization. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "Fever"; NAUSEA (non-serious), outcome "unknown", described as "Nausea".  No follow-up attempts are possible. No further information is expected.
first turned blue & limp about 8PM;pt last ate 5PM;unable to get infant to eat p/that;1AM 7/3/99 mom noticed pt blue again;mom tried to feed pt but infant vomited;pt to ER per MD
tightness in chest; muscle spasm,cramps in calves; loss of appetite; body ache; joint pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (tightness in chest), MUSCLE SPASMS (muscle spasm,cramps in calves), DECREASED APPETITE (loss of appetite), MYALGIA (body ache) and ARTHRALGIA (joint pain) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.    On 30-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced CHEST DISCOMFORT (tightness in chest), MUSCLE SPASMS (muscle spasm,cramps in calves), DECREASED APPETITE (loss of appetite), MYALGIA (body ache), ARTHRALGIA (joint pain) and FATIGUE (fatigue). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, CHEST DISCOMFORT (tightness in chest), DECREASED APPETITE (loss of appetite), MYALGIA (body ache), ARTHRALGIA (joint pain) and FATIGUE (fatigue) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter. Treatment medication included Ibuprofen.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.
side effects/experienced a side effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects/experienced a side effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects/experienced a side effect). At the time of the report, VACCINATION COMPLICATION (side effects/experienced a side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported by the reporter. No treatment was reported by the reporter.
Around 8 PM I started feeling aches and pains in my joints as if I had exercised heavily that day.  Lots of aches and pains in joints throughout the night making sleep difficult.  Also felt very warm sometimes, and then cold - almost as if I were on the outset of a cold/flu.  It's now almost noon time on 9/25/10 and I'm starting to feel better.
Pharmacy technician was vaccinating patient and when disposing of needle sharp it bounced off the sharps container and she tried to push down the needle into the sharps container and pricked herself.
Site of injection plus whole arm: shoulders to elbow red/swollen/itching.  24 hours after vaccine administered. (Right arm).
MISTAKENLY ADMINISTERED MODERNA VACCINE TO 16 YO.  NO ADVERSE EVENTS YET.
Upset stomach; heartburn; Gas; diarrhea - for around 48 hours. Fatigue also - maybe longer - about 60 hours. Tried to keep hydrated. Didn't see the doctor.
No additional AE details available; improperly stored vaccine administered to patient; This spontaneous report as received from a physician refers to a patient of unknown age and gender. Concomitant therapies, medical history and historical drugs were not provided.  On 26-AUG-2020, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live rHA (recombinant Human albumin) (PROQUAD) lot # T007396 (expiration date 29-AUG-2021), 0.5 milliliter for prophylaxis (strength, frequency and route of administration were not reported).    Temperature excursion was reported as 16.07 degree fahrenheit  (°F) for 25 minutes with no previous temperature excursion.   The call was made due to a digital data logger. No adverse symptoms were reported.
Client was vaccinated for Covid with Moderna vaccines on March 2 and March 30, 2021.  Client had Covid symtoms that started on 7/15/2021: runny nose, sneezing, cough, loss of taste and smell.  Tested positive with rapid test on 7/20/2021.  Reported because this is a case of Covid in a previously fully vaccinated person.
pt recv vax; mom reported that pt went to er p/ shots of 4jan94 w/ rash, fever 104.7 & v;MD said was rxn to Hep B vax;
Information regarding influenza virus vaccine, trivalent, A&B, was received from a consumer regarding a 24 year old male patient who experienced red striations out from injection site and injection site reaction. At 10 years of age, the patient received a dose on an unspecified date. No allergies to eggs. Indication for influenza virus vaccine, trivalent, A&B was immunization. Product was administered on an unspecified date. Dose regimen was not provided. Patient was not taking concomitant therapy. On an unspecified date, sometime during 1988-1989, at the age of 10 years, the patient received a dose of influenza virus vaccine and developed an injection site reaction of the arm characterized by red striations radiating out from the injection site. The reaction lasted for a day or so and resolved with an unknown dose of Benadryl. No additional information was available at the time of this report.
Patient had no known side effects; Vaccine Coordinator reported a temperature excursion for  which was supported.; This spontaneous report was received from a vaccine coordinator and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history, allergies and concomitant therapies provided.  On 30-DEC-2021, the patient was vaccinated  with incorrectly stored one dose of hepatitis a vaccine, inactivated (VAQTA) lot # U024094,  lot number established to be valid, with expiration date 10-MAY-2023 (formulation, exact dose, route of administration, anatomical location were not reported) for prophylaxis (product storage error).  The patient had no known side effects (no adverse event).; Sender's Comments:  US-009507513-2201USA006297:
Sore arm; Pulled the dose from multiple vials (2-3 vials) to complete the 0.5ML; A spontaneous report was received from a pharmacist, concerning her mother, a 57-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) where in pulled the dose from multiple vials (2-3 vials) to complete the 0.5 ML and developed sore arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.     On 16 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot: 00UM20A) for prophylaxis of COVID-19 infection.   On 16 Feb 2021, the patient's vaccine dose was pulled the from multiple vials (2-3 vials) to complete the 0.5 ML. Patient also experienced sore arm. Laboratory details not provided. No treatment information was provided.    Action taken with mRNA-1273 in response to the events were not reported.     The outcome of the event Pulled the dose from multiple vials (2-3Vials) to complete the 0.5ML was considered resolved on 16 Feb 2021. The outcome of event sore arm was considered unknown at the time of this report.; Reporter's Comments: This report refers to a case of Inappropriate drug extraction with syringe for mRNA-1273, lot # 00UM20A with sore arm. developed
Narrative:  pt is a 72 year old male complaining of facial edema, lips tingling and sl tongue swelling after receiving COVID vaccin. pt was in drive thru waiting and developed these symptoms. no soa, no cp. no prior reaction. Pt was given Benadryl 25 mg, prednisone 60 mg and watched for 30 min. Pt had no signs of allergic reaction on exam, luings clear no facial edema, no tongue edema no uvular edema. Pt's wife states he looks normal to her. Pt seen by ER MD.. After 30 min, pt felt better. pt advised to take Benadryl 25 mg in 4 hrs. He voiced understanding.
Patient received Pneumonia vaccination and experienced swelling at injection site, redness and bruising down entire arm. (Right arm only). When she came to pharmacy, everything subsided other than some bruising.
Office visit on 8/27/01 revealed on back of right hand and scattered on lateral arm from tip to shoulder vesicular clusters and isolates with significant erythema and discomfort with palpation. Pt was placed on Acyclovir.
Immediately after vaccine shot: burning sensation at the site of injection for a few minutes  Approximately 2 hours after injection: body aches, specifically in my upper back  Morning of Tuesday 3/23 (6:15AM): Woke up with a minor headache and upper back aches  Tuesday 3/23 Afternoon (11AM): headache slightly worsened, body aches slightly worsened and spread to include both my upper and lower back, 100.7 degrees Fahrenheit fever, chills, had a slight cough that lasted about 2-3 hours  Tuesday 3/23 evening: headache worsened to a migraine, body aches worsened and spread to include my neck, upper back, and lower back, stiffness, 100.7 degrees Fahrenheit fever, chills, fatigue  Tuesday evening at 9PM: Fever broke and my temperature returned back to normal, all other symptoms remained  Wednesday (3/24) Morning (6:15AM): woke up with minor upper back aches
Two days post vaccine given arm swelled and became painful. Pt placed on ABX. F/U two weeks following and no c/o problem.
Client received full series of Covid vaccinations, Pfizer vaccines on March 10 and the second vaccine on April 1, 2021.  Client then tested positive for Covid with rapid test on 7/13/2021.  Also had symptoms of Covid (chills, fever 101, nasal congestion, diarrhea, fatigue, headache, myalgia, sore throat) that started on 7/10/2021.  Reported because this is a case of breakthrough Covid illness s/p full vaccination.
22FEB fever 105, vomiting during the noc;22FEB 2mm papules on trunk & face;23FEB rash spreading newer ones interspersed w/older;